Covid-19 Vaccines

 

The 2026-2027 Covid-19 Vaccine was approved by the FDA on August 27, 2026.  As soon as vaccine is shipped and available at our pharmacy we will open the calendar. 

mnexspike by Moderna 26-27 COVID-19 VACCINE (Age 12+)

Underlying Conditions and Higher Risk for Severe COVID-19

For patients 12-64 you will be asked to attest to one of the following conditions.

  • Asthma
  • Cancer
  • Cerebrovascular disease
  • Chronic kidney disease
  • Chronic lung diseases, limited to bronchiectasis, COPD (Chronic Obstructive Pulmonary Disease), interstitial lung disease, pulmonary embolism, pulmonary hypertension
  • Chronic liver diseases, limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, autoimmune hepatitis
  • Cystic fibrosis
  • Diabetes mellitus, type 1 and type 2
  • Disabilities, including Down syndrome (complete list included here)
  • Epilepsy
  • Heart conditions (such as heart failure, coronary artery disease, or cardiomyopathies)
  • Hemophilia
  • HIV (human immunodeficiency virus)
  • Mental health conditions, limited to mood disorders (including depression), schizophrenia spectrum disorders
  • Neurologic conditions, limited to dementia and Parkinson’s Disease
  • Overweight (BMI >30 )
  • Physical inactivity
  • Pregnancy or recent pregnancy
  • Primary immunodeficiencies
  • Sickle cell disease
  • Smoking, current or former
  • Solid organ or blood stem cell transplantation
  • Tuberculosis
  • Use of corticosteroids or other immunosuppressive medications
 

Looking For A Rapid Test?

Click Here

Back to Immunizations

Back to Top